(Q34320789)

1 August 2017

1 reference

title

Pharmacokinetics of antifungal agents in onychomycoses (English)

1 reference

1 August 2017

1 reference

Debruyne D

1

1 reference

1 August 2017

Coquerel A

series ordinal

2

1 reference

1 August 2017

publication date

1 January 2001

1 reference

Clinical Pharmacokinetics

1 August 2017

published in

1 reference

1 August 2017

volume

40

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

441-472

1 reference

Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Enhancing effect of N-acetyl-l-cysteine or 2-mercaptoethanol on the in vitro permeation of 5-fluorouracil or tolnaftate through the human nail plate.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Effects of ranitidine and sucralfate on ketoconazole bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Itraconazole pharmacokinetics in patients with renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140060-00005

Itraconazole and anti-tuberculosis drugs

21 January 2018

1 reference

12 December 2020

Short-duration treatment of fingernail dermatophytosis: a randomized, double-blind study with terbinafine and griseofulvin. LAGOS III Study Group

1 reference

12 December 2020

Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases.

1 reference

12 December 2020

Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations

1 reference

12 December 2020

Pharmacokinetics of three once-weekly dosages of fluconazole (150, 300, or 450 mg) in distal subungual onychomycosis of the fingernail

1 reference

12 December 2020

Treatment of onychomycosis: traditional approaches

1 reference

12 December 2020

Pharmacokinetic optimisation of oral antifungal therapy

1 reference

12 December 2020

Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.

1 reference

12 December 2020

Assay of itraconazole in nail clippings by reversed phase, high performance liquid chromatography

1 reference

12 December 2020

Effect of fluconazole on theophylline disposition in humans

1 reference

12 December 2020

Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis

1 reference

12 December 2020

Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once daily for 7 and 14 days

1 reference

12 December 2020

Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once-weekly versus twice-weekly

1 reference

12 December 2020

Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men.

1 reference

12 December 2020

Therapeutic efficacy and safety of one-week intermittent therapy with itraconazole for onychomycosis in a Chinese patient population.

1 reference

12 December 2020

Clinical and pharmacokinetic investigations of oral terbinafine in patients with tinea unguium

1 reference

12 December 2020

Terbinafine in onychomycosis of the toenail: A novel treatment protocol

1 reference

12 December 2020

Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.

1 reference

12 December 2020

Determination of terbinafine in nail samples during systemic treatment for onychomycoses

1 reference

12 December 2020

Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography

1 reference

12 December 2020

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

1 reference

12 December 2020

Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections

1 reference

12 December 2020

Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses

1 reference

12 December 2020

Ketoconazole and fungal CAPD peritonitis

1 reference

12 December 2020

Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach

1 reference

12 December 2020

Terbinafine levels in serum, stratum corneum, dermis-epidermis (without stratum corneum), hair, sebum and eccrine sweat

1 reference

12 December 2020

The effect of ingestion time interval on the interaction between itraconazole and triazolam

1 reference

12 December 2020

Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis

1 reference

12 December 2020

Treatment of onychomycosis with nail avulsion and topical ketoconazole

1 reference

12 December 2020

Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview)

1 reference

12 December 2020

Scopulariopsis onychomycosis treated with natamycin

1 reference

12 December 2020

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: A multicenter study with 36 patients

1 reference

12 December 2020

Coadministration of rifampin and itraconazole leads to undetectable levels of serum itraconazole

1 reference

12 December 2020

Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up

1 reference

12 December 2020

Oral antifungal drug interactions

1 reference

12 December 2020

Terbinafine. An update of its use in superficial mycoses

1 reference

12 December 2020

Serum binding of ketoconazole in health and disease

1 reference

12 December 2020

Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.

1 reference

12 December 2020

[Cyclosporin A and ketoconazole, drug interaction or therapeutical combination?]

1 reference

12 December 2020

Interaction between tolbutamide and ketoconazole in healthy subjects

1 reference

12 December 2020

The effect of keratolytic agents on the permeability of three imidazole antimycotic drugs through the human nail

1 reference

12 December 2020

Interaction of itraconazole and digoxin

1 reference

12 December 2020

A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis

1 reference

12 December 2020

Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole.

1 reference

12 December 2020

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis

1 reference

12 December 2020

The clinical pharmacokinetics of itraconazole: an overview

1 reference

12 December 2020

Onychomycosis: a significant medical disorder.

1 reference

12 December 2020

Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction

1 reference

12 December 2020

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

12 December 2020

Topical treatment of nail and skin infections with miconazole, a new broad-spectrum antimycotic

1 reference

12 December 2020

Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly

1 reference

12 December 2020

Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.

1 reference

12 December 2020

Continuous and intermittent itraconazole dosing schedules for the treatment of onychomycosis: a pharmacokinetic comparison

1 reference

12 December 2020

Long-term post-treatment follow-up of onychomycosis treated with terbinafine: a multicentre trial

1 reference

12 December 2020

"Endonyx" onychomycosis: a new modality of nail invasion by dermatophytes

1 reference

12 December 2020

Determination of terbinafine and its desmethyl metabolite in human plasma by high-performance liquid chromatography

1 reference

12 December 2020

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole

1 reference

12 December 2020

Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients

1 reference

12 December 2020

German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection

1 reference

12 December 2020

Serum itraconazole and hydroxyitraconazole concentrations and interaction with digoxin in a case of chronic hypertrophic pachymenigitis caused by Aspergillus flavus

1 reference

12 December 2020

Levels of fluconazole in normal and diseased nails during and after treatment of onychomycoses in toe-nails with fluconazole 150 mg once weekly

1 reference

12 December 2020

Antifungal agents: an overview. Part II.

1 reference

12 December 2020

Pharmacokinetics of fluconazole in pediatric patients

1 reference

12 December 2020

Effect of route of administration of fluconazole on the interaction between fluconazole and midazolam.

1 reference

12 December 2020

New therapies for onychomycosis

1 reference

12 December 2020

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail

1 reference

12 December 2020

Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial.

1 reference

12 December 2020

Current management of onychomycosis. An overview

1 reference

12 December 2020

Non-traumatic topical treatment of onychomycosis with urea associated with bifonazole

1 reference

12 December 2020

Levels of terbinafine in plasma, stratum corneum, dermis-epidermis (without stratum corneum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks

1 reference

12 December 2020

Kinetics of amorolfine in human nails.

1 reference

12 December 2020

Nail incorporation kinetics of terbinafine in onychomycosis patients

1 reference

12 December 2020

Rifampin-fluconazole interaction in critically ill patients

1 reference

12 December 2020

The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect

1 reference

12 December 2020

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

1 reference

12 December 2020

Interaction between cyclosporine and fluconazole in renal allograft recipients

1 reference

12 December 2020

Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Management of toenail onychomycosis

1 reference

12 December 2020

Treatment of superficial white onychomycosis with topical terbinafine cream

1 reference

12 December 2020

Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses

1 reference

12 December 2020

Ketoconazole inhibition of triazolam and alprazolam clearance: differential kinetic and dynamic consequences

1 reference

12 December 2020

Clinical pharmacokinetics of fluconazole

1 reference

12 December 2020

Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent

1 reference

12 December 2020

A comparison among four regimens of itraconazole treatment in onychomycosis

1 reference

12 December 2020

Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum

1 reference

12 December 2020

Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis

1 reference

12 December 2020

Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?

1 reference

12 December 2020

Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis

1 reference

12 December 2020

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

1 reference

12 December 2020

Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin

1 reference

12 December 2020

Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis

1 reference

12 December 2020

Treatment of Onychomycosis by Partial Nail Avulsion and Topical Miconazole

1 reference

12 December 2020

Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics

1 reference

12 December 2020

Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions

1 reference

12 December 2020

Costs of therapy for dermatophyte infections

1 reference

12 December 2020

Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.

1 reference

12 December 2020

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis

1 reference

12 December 2020

Fluconazole-nortriptyline drug interaction

1 reference

12 December 2020

Current topics in diagnosis and treatment of tinea unguium in Japan

1 reference

12 December 2020

Drug interactions with fluconazole

1 reference

12 December 2020

Dose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteers

1 reference

12 December 2020

Possible interaction between phenobarbital, carbamazepine and itraconazole

1 reference

12 December 2020

An intermittent itraconazole 1-week dosing regimen for the treatment of toenail onychomycosis in dermatological practice

1 reference

12 December 2020

Factors affecting plasma levels of ketoconazole during long-term treatment.

1 reference

12 December 2020

Pharmacokinetics of fluconazole in normal volunteers

1 reference

12 December 2020

Fluconazole-cyclosporine interaction: a dose-dependent effect?

1 reference

12 December 2020

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial

1 reference

12 December 2020

Hepatic injury during ketoconazole therapy in patients with onychomycosis: a controlled cohort study

1 reference

12 December 2020

Onychomycosis: therapeutic update

1 reference

12 December 2020

The impact of onychomycosis on quality of life.

1 reference

12 December 2020

Effect of fluconazole dose on the extent of fluconazole-triazolam interaction

1 reference

12 December 2020

Torsades de pointes occurring in association with terfenadine use

1 reference

12 December 2020

Management of onychomycoses

1 reference

12 December 2020

Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail

1 reference

12 December 2020

Azole Antifungal Agents

1 reference

12 December 2020

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group

1 reference

12 December 2020

Safety and pharmacokinetics of fluconazole in children with neoplastic diseases

1 reference

12 December 2020

The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects.

1 reference

12 December 2020

Warfarin-griseofulvin interaction

1 reference

12 December 2020

Newer systemic antifungal drugs for the treatment of onychomycosis

1 reference

12 December 2020

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

12 December 2020

Open-label study of the safety and efficacy of naftifine hydrochloride 1 percent gel in patients with distal subungual onychomycosis of the fingers

1 reference

12 December 2020

Fungicidal versus fungistatic activity of terbinafine and itraconazole: an in vitro comparison

1 reference

12 December 2020

Pharmacokinetics of terbinafine in the nail

1 reference

12 December 2020

[Pharmacokinetic interaction of ketoconazole, isoniazid and rifampicin]

1 reference

12 December 2020

Clinical pharmacokinetics of ketoconazole

1 reference

12 December 2020

Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers

1 reference

12 December 2020

Loceryl nail lacquer--realization of a new galenical approach to onychomycosis therapy

1 reference

12 December 2020

Causative pathogens in onychomycosis and the possibility of treatment resistance: a review.

1 reference

12 December 2020

Treatment of toenail onychomycosis with 2% butenafine and 5% Melaleuca alternifolia (tea tree) oil in cream

1 reference

12 December 2020

A new classification of onychomycosis

1 reference

12 December 2020

Hypoglycemic coma in a patient treated with glipizide and fluconazole: a possible interaction?

1 reference

12 December 2020

Efficacy and safety of bifonazole urea in the two-phase treatment of onychomycosis

1 reference

12 December 2020

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day

1 reference

12 December 2020

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail

1 reference

12 December 2020

Human plasma and skin blister fluid levels of griseofulvin after its repeated administration

1 reference

12 December 2020

Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole

1 reference

12 December 2020

The uptake of fluconazole in finger and toe nails

1 reference

12 December 2020

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group.

1 reference

12 December 2020

Treatment of onychomycosis by ODT therapy with 20% urea ointment and 2% tolnaftate ointment

1 reference

12 December 2020

Onychomycosis: diagnosis and systemic treatment

1 reference

12 December 2020

Mycological and Clinical Evaluation of Griseofulvin for Chronic Onychomycosis

1 reference

12 December 2020

Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites

1 reference

12 December 2020

Plasma concentrations of griseofulvin in healthy volunteers and out-patients treated for onychomycosis

1 reference

12 December 2020

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

1 reference

12 December 2020

Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.

1 reference

12 December 2020

Digoxin-itraconazole interaction: possible mechanisms

1 reference

12 December 2020

A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis

1 reference

12 December 2020

Onychomycosis: recognition, diagnosis, and management

1 reference

12 December 2020

Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up.

1 reference

12 December 2020

Drug-induced nail disorders: incidence, management and prognosis

1 reference

12 December 2020

Fluconazole for the treatment of onychomycosis: an update

1 reference

12 December 2020

Onychomycosis: a compendium of facts and a clinical experience

1 reference

12 December 2020

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance

1 reference

12 December 2020

Itraconazole penetrates the nail via the nail matrix and the nail bed--an investigation in onychomycosis

1 reference

12 December 2020

Comparative bioavailability of a microsize and ultramicrosize griseofulvin formulation in man

1 reference

12 December 2020

Fluconazole: a new triazole antifungal agent

1 reference

12 December 2020

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy

1 reference

12 December 2020

Treatment of Candida nail infection with terbinafine

1 reference

12 December 2020

10.2165/00003088-200140060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1046692355

0 references

1 reference